Precision Therapeutics Enhances Their Straightforward Approach to Personalizing Cancer Care

Sean McDonald handles growth and change at Precision Therapeutics Inc.

Precision Therapeutics Post: Issue 10

Sean McDonald Featured in Smart Business

Precision's Kord Kozma is one of Thirteen Human Resources Professionals Honored at Pittsburgh Business Time's 2011 HR Leadership Awards

See Precision's Profile on the Inc. 500/5000

Precision Therapeutics Presents Multi-Gene Breast Cancer Studies at 2011 Breast Cancer Symposium

Precision Therapeutics Inc. Prepares to Bring New Products to Market

Precision Therapeutics Named on Inc. 500|5000 2011 List and Recognized for Achievements in Personalized Medicine Industry

Precision Therapeutics’ Largely Young Workforce is Helping Patients Fight Cancer with Individualized Drug Therapies

Precision Therapeutics Presents Clinical Study Emphasizing the Role of ChemoFx^® in Directing Chemotherapy in Gynecologic Cancers

Precision Therapeutics Demonstrates Utility of Multi-Gene Predictors in Predicting Chemotherapy Response for Breast Cancer Patients

Precision Therapeutics Post: Issue 9

Video (may take time to download): Precision Investor Bain Capital Ventures

Hear Sean McDonald Interviewed on Health Talk Radio!

Med Biogene Announces Closing of Partnership With Precision Therapeutics to Commercialize LungExpress DX

Precision Therapeutics' ChemoFx^® Demonstrates Significant Role In Selection of Chemotherapy Doublets In Non Small Cell Lung Cancer

Precision Therapeutics Announces New Tumor Profiling Product to Augment Utility of ChemoFx^® and Further Personalize Cancer Treatment

Interview by WTAE Radio: The American Entrepreneur: How Precision Therapeutics Survived the Recession: A Conversation with CEO Sean McDonald and Ron Morris

Video: Sean McDonald Interviewed by Our Region's Business

Precision Therapeutics and Med BioGene Partner to Commercialize LungExpress Dx^TM

Precision Therapeutics Announces Two Pancreatic Cancer Studies Emphasizing the Utility of ChemoFx in Cancer Treatment Options

Precision Therapeutics Announces New Study on Multi-Gene Predictors at 2010 San Antonio Breast Cancer Symposium

Precision Therapeutics To Present Abstracts At 33rd Annual San Antonio Breast Cancer Symposium

Precision Therapeutics President and CEO Sean McDonald Recognized as Pittsburgh Technology Council Tech 50 CEO of the Year

more news »

2012 Events Sponsored by Precision Therapeutics

Show	Dates	Location Of Show
ASCO 2012 GI Cancers Symposium www.asco.org	Jan. 19-21, 2012	San Francisco, CA
GOG Semi-Annual Meeting www.gog.org	Jan. 26-29, 2012	San Diego, CA
STS 48th Annual Meeting www.sts.org	Jan. 28-Feb. 1, 2012	Fort Lauderdale, FL
SGO Winter Meeting www.sgo.org	Feb. 9-11, 2012	Olympic Valley, CA
SGO Annual Meeting www.sgo.org	March 24-27, 2012	Austin, TX
American Society of Colon and Rectal Surgeons www.fascrs.org	June 2-6, 2012	San Antonio, TX
OCNA Annual Conference www.ovariancancer.org	TBA	Washington, DC